From the “obvious study results” department:
When a drug company or device-maker is funding a clinical trial for a new cardiovascular treatment, the reported outcome is likely to reveal good news for the new treatment, according to researchers here.
Likewise when funding comes from non-profit sources, the outcomes are less likely to favor the new treatments and when for-profit and not-for-profit funders split the tab, the results are, in the words of Goldilocks, “just right.”
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
